Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/1998
12/01/1998US5843638 Nucleic acids and pepties of human immunodeficiency virus type-1 (HIV-1).
12/01/1998US5843636 Hepatitis C virus epitopes
12/01/1998US5843634 Genetically engineered enzymes and their conjugates for diagnostic assays
12/01/1998US5843633 Characterization of a human hematopoietic progenitor cell antigen
12/01/1998US5843459 Differential inactivation of nucleic acids by chemical modification
12/01/1998US5843458 Recombinant human cytomegalovirus having a US2 deletion
12/01/1998US5843456 Alvac poxvirus-rabies compositions and combination compositions and uses
12/01/1998US5843454 HIV immunogenic complexes
12/01/1998US5843450 Hepatitis GB Virus synthetic peptides and uses thereof
12/01/1998US5843449 Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
12/01/1998US5843448 Tumor rejection antigen precursor
12/01/1998US5843444 Conjugate vaccine for group B streptococcus
12/01/1998US5843441 Use of endothelial-leukocyte adhesion molecule-1 specific antibodies in the treatment of asthma
12/01/1998US5843439 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
12/01/1998US5843432 Retroviral vectors for the treatment of tumors, and cell lines containing them
12/01/1998US5843431 Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation
12/01/1998US5843426 Salmonella vaccines
12/01/1998US5843423 Methods of stimulating hematopoietic cells with flt3-ligand
12/01/1998US5843405 Epstein-Barr virus peptides and antibodies against these peptides
12/01/1998CA1340157C Hiv peptides and methods for detection of hiv
11/1998
11/30/1998CA2233580A1 Histidine kinase
11/30/1998CA2233577A1 Histidine kinase
11/30/1998CA2233572A1 Histidine kinase
11/30/1998CA2233554A1 Novel compounds
11/30/1998CA2233547A1 Histidine kinase
11/30/1998CA2233539A1 Histidine kinase
11/29/1998CA2233565A1 Novel compounds
11/29/1998CA2233561A1 Novel compounds
11/29/1998CA2231723A1 Novel has2 splicing variant hoefc11: a target in chronic renal failure, inflammatory diseases and myocardial schemia
11/27/1998CA2232817A1 Novel compounds
11/27/1998CA2232814A1 Novel compounds
11/26/1998WO1998053104A2 Detection of retroviral subtypes based upon envelope specific sequences
11/26/1998WO1998053103A1 Nucleic acid arrays
11/26/1998WO1998053102A1 Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases
11/26/1998WO1998053101A2 Methods and composition to identify swine genetically resistant to f18 e. coli associated diseases
11/26/1998WO1998053100A1 Method based on the use of bacteriophages for the detection biological molecules in biological samples
11/26/1998WO1998053099A1 Method for detecting qualitative and quantitative alterations in dna and ligands of said alteration ligands
11/26/1998WO1998053098A1 Method and kit for detecting dna mutations using restriction enzymes
11/26/1998WO1998053092A1 Method and system for performing a binding assay
11/26/1998WO1998053088A1 Improved transaminase biotransformation process
11/26/1998WO1998053087A1 Method for the production of non-group c adenoviral vectors
11/26/1998WO1998053086A1 Sucrose-binding proteins
11/26/1998WO1998053085A1 Genetic control of fruit ripening
11/26/1998WO1998053084A1 Enhancement of erythromycin production by expression of a cloned oxygen-binding protein
11/26/1998WO1998053083A1 Gene silencing
11/26/1998WO1998053081A1 Enantioselective epoxide hydrolases and genes encoding these
11/26/1998WO1998053080A1 Polyphenol oxidase genes from banana, tobacco and pineapple
11/26/1998WO1998053079A1 Ubiquitin conjugation proteins
11/26/1998WO1998053078A1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
11/26/1998WO1998053077A1 Live attenuated virus vaccines for equine encephalitis viruses
11/26/1998WO1998053076A2 Compounds for diagnosis of tuberculosis and methods for their use
11/26/1998WO1998053075A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
11/26/1998WO1998053074A1 Large subunit ribosomal dna of neospora species
11/26/1998WO1998053073A1 A plant disease resistance signalling gene, materials and methods relating thereto
11/26/1998WO1998053072A1 The production of human granulocyte colony-stimulating factor
11/26/1998WO1998053071A1 Modulators of tissue regeneration
11/26/1998WO1998053070A1 Human gp12 homolog
11/26/1998WO1998053069A2 Gdnf receptors
11/26/1998WO1998053068A1 Smad7 and uses thereof
11/26/1998WO1998053067A1 Nbc, a gene that encodes a member of the bicarbonate transporter family of proteins
11/26/1998WO1998053066A1 Smad2 phosphorylation and interaction with smad4
11/26/1998WO1998053065A1 Human semaphorin e and polynucleotides encoding it
11/26/1998WO1998053064A1 Organic anion transporter and gene coding for the same
11/26/1998WO1998053063A2 Mammalian cell transduction for use in gene therapy
11/26/1998WO1998053062A1 A human edg-6 receptor homologue
11/26/1998WO1998053061A1 Three novel genes encoding a zinc finger protein, a guanine, nucleotide exchange factor and a heat shock protein or heat shock binding protein
11/26/1998WO1998053060A1 Nucleic acid binding proteins
11/26/1998WO1998053058A1 Nucleic acid binding proteins
11/26/1998WO1998053057A1 Nucleic acid binding polypeptide library
11/26/1998WO1998053056A2 Method for producing long dna constructs
11/26/1998WO1998053055A1 Grapevine leafroll virus (type 2) proteins and their uses
11/26/1998WO1998053054A1 Dna encoding canine interleukin-1 receptor antagonist
11/26/1998WO1998053053A2 Dna encoding an arthropod chitin synthase
11/26/1998WO1998053052A1 Sialidases localized on plasma membranes and dna encoding the same
11/26/1998WO1998053049A1 Vascular adhesion protein-1 having amine oxidase activity
11/26/1998WO1998052975A1 Mutated okt3 antibody
11/26/1998WO1998052972A1 Novel protein, its gene, reagents for inducing apoptosis, and anticancer agents
11/26/1998WO1998052964A1 Rupestris stem pitting associated virus nucleic acids, proteins, and their uses
11/26/1998WO1998052963A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
11/26/1998WO1998052958A1 Human uncoupling protein 3
11/26/1998WO1998052607A1 88kda tumorigenic growth factor and antagonists
11/26/1998WO1998052597A1 Apoptosis-inducing gelsolin sequences
11/26/1998WO1998052595A1 Peptide nucleic acid monomers and oligomers
11/26/1998WO1998052591A1 Glial cell line-derived neurotrophic factor receptors
11/26/1998WO1998052581A1 Vectors and methods for immunization or therapeutic protocols
11/26/1998WO1998052415A1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
11/26/1998WO1998046770A3 Stable biocatalysts for ester hydrolysis
11/26/1998WO1998041539A3 Secreted proteins and polynucleotides encoding them
11/26/1998WO1998039448A3 186 human secreted proteins
11/26/1998WO1998037209A3 Expression vector for the permanent expression of foreign dna
11/26/1998WO1998037185A3 Vectors for controlled gene expression
11/26/1998WO1998032847A3 Characterization of the yeast transcriptome
11/26/1998WO1998031818A3 Tace-like and matrilysin-like polypeptides
11/26/1998WO1998031800A3 Human proteins
11/26/1998WO1998030582A3 Secreted proteins and polynucleotides encoding them
11/26/1998WO1998029537A3 Method for protecting plants
11/26/1998WO1998028320A3 Affinity based self-assembly systems and devices for photonic and electronic applications
11/26/1998WO1998021323A3 Reversal of drug resistance through oligonucleotide complementary to plasmodium falciparum specific region
11/26/1998WO1998008954A3 Production of heme and recombinant hemoproteins
11/26/1998DE19755960C1 Braking open a structure of e.g. microorganism or cell
1 ... 3463 3464 3465 3466 3467 3468 3469 3470 3471 3472 3473 3474 3475 3476 3477 3478 3479 3480 3481 3482 3483 ... 4023